表紙
市場調查報告書

三次元細胞培養的全球市場的預測 ∼2024年:支架型 (水凝膠/ECM類比、固體支架)、無支架型 (懸滴、生物反應器)、微流體、磁浮 & 生物印刷

3D Cell Culture Market by Product (Hydrogel, Hanging Drop, Bioreactor, Microfluidics, Magnetic Levitation), Application (Cancer, Stem Cell, Toxicology, Tissue Engineering), End User (Pharmaceutical, Biotech, Cosmetics), Region - Global Forecast to 2024

出版商 MarketsandMarkets 商品編碼 363063
出版日期 內容資訊 英文 156 Pages
訂單完成後即時交付
價格
Back to Top
三次元細胞培養的全球市場的預測 ∼2024年:支架型 (水凝膠/ECM類比、固體支架)、無支架型 (懸滴、生物反應器)、微流體、磁浮 & 生物印刷 3D Cell Culture Market by Product (Hydrogel, Hanging Drop, Bioreactor, Microfluidics, Magnetic Levitation), Application (Cancer, Stem Cell, Toxicology, Tissue Engineering), End User (Pharmaceutical, Biotech, Cosmetics), Region - Global Forecast to 2024
出版日期: 2019年12月10日內容資訊: 英文 156 Pages
簡介

全球三次元 (3D) 細胞培養的市場在預測期間內預計將以15.7%的年複合成長率 (CAGR) 發展,從2019年的8億9,200萬美元,成長到2024年18億4,600萬美元的規模。該市場的成長主要由於動物實驗的替代手法的開發受到高度關注,個人化醫療意願的擴大,慢性疾病的發病率增加,及研究資金的可用性等而受到促進。另一方面,3D細胞培養研究的基礎設施的不足及細胞生物學研究高額的成本預計抑制在預測期間內該市場的成長。

本報告提供全球三次元 (3D) 細胞培養的市場調查,市場及技術概要,市場成長的影響因素及市場機會分析,各產品、用途、終端用戶、地區/主要國家趨勢與市場規模的變化與預測,競爭環境與市場佔有率,主要企業簡介等資訊彙整。

第1章 簡介

第2章 調查手法

第3章 摘要整理

第4章 重要考察

  • 3D細胞培養市場概要
  • 支架型3D細胞培養市場:各類型
  • 3D細胞培養市場佔有率:各終端用戶、地區
  • 3D細胞培養市場:地區的成長機會

第5章 市場概要

  • 簡介
  • 市場動態
    • 推動要素
    • 阻礙因素
    • 市場機會
    • 課題

第6章 3D細胞培養市場:各產品

  • 簡介
  • 支架型
    • 水凝膠/ECM類比
    • 固體支架
    • 微加工表面
  • 無支架型
    • 超低黏合板
    • 懸滴板
    • 3D生物反應器
    • 3D培養皿
  • 微流體型3D細胞培養
  • 磁浮 & 生物印刷3D細胞培養

第7章 3D細胞培養市場:各用途

  • 簡介
  • 癌症、幹細胞研究
  • 藥物研發、毒性檢驗
  • 組織工程、再生醫療

第8章 3D細胞培養市場:各終端用戶

  • 簡介
  • 醫藥品、生物科技企業
  • 研究機關
  • 化妝品產業
  • 其他終端用戶

第9章 3D細胞培養市場:各地區

  • 簡介
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 其他
  • 其他地區

第10章 競爭環境

  • 概要
  • 市場佔有率分析
  • 競爭領導製圖
  • 競爭情形、趨勢

第11章 企業簡介

  • THERMO FISHER SCIENTIFIC
  • CORNING INCORPORATED
  • MERCK KGAA
  • LONZA GROUP
  • REPROCELL
  • 3D BIOTEK LLC
  • EMULATE, INC.
  • CN BIO INNOVATIONS LIMITED
  • HAMILTON COMPANY
  • INSPHERO AG
  • KIRKSTALL, LTD.
  • MIMETAS BV
  • TISSUSE GMBH
  • SYNTHECON INCORPORATED
  • QGEL SA
  • 其他的主要企業

第12章 附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: BT 4414

"The global 3D cell culture market is projected to grow at a CAGR of 15.7% during the forecast period."

The 3D cell culture market is projected to reach USD 1,846 million by 2024 from USD 892 million in 2019, at a CAGR of 15.7%. The growth in this market is primarily driven by the increasing focus on developing alternatives to animal testing, growing focus on personalized medicine, increasing incidence of chronic diseases, and the availability of funding for research. On the other hand, the lack of infrastructure for 3D cell-based research and the high cost of cell biology research are expected to limit market growth during the forecast period.

"The microfluidics-based 3D cell cultures segment is projected to grow at the highest CAGR during the forecast period."

Based on product, the 3D cell culture market is segmented into scaffold-based, scaffold-free, microfluidics-based, and magnetic & bioprinted 3D cell cultures. The microfluidics-based segment is expected to register the highest CAGR during the forecast period. Funding initiatives from various government and private investors are among the key factors driving the growth of this market.

"The cancer and stem cell research segment accounted for the largest share of the 3D cell culture market in 2018."

On the basis of application, the 3D cell culture market is segmented into cancer & stem cell research, drug discovery & toxicology testing, and tissue engineering & regenerative medicine. The cancer & stem cell research segment accounted for the largest share of the market in 2018. The increasing prevalence of cancer and significant funding initiatives for cancer research from the government as well as the private sector are some of the major factors driving the growth of this application segment.

"Europe to witness high growth during the forecast period."

Based on region, the 3D cell culture market is segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). The European market is expected to grow at the highest CAGR owing to the growth of the pharmaceutical and biotechnology industry, increasing incidence of cancer, growing number of venture capital investments, strategic expansion of market players in the region, recent commercialization of microfluidic-based products, increasing presence of major market players, and the large number of research activities in the region.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type: Tier 1: 50%, Tier 2: 30%, and Tier 3: 20%
  • By Designation: C-level: 37%, D-level: 29%, and Others: 34%
  • By Region: North America: 38%, Europe: 23%, Asia: 30%, and the RoW: 9%

List of companies profiled in this report:

  • Thermo Fisher Scientific (US)
  • Corning Incorporated (US)
  • Merck (Germany)
  • Lonza AG (Switzerland)
  • REPROCELL Incorporated (Japan)
  • TissUse (Germany)
  • InSphero (Switzerland)
  • Synthecon (US)
  • 3D Biotek (US)
  • CN Bio (UK)
  • Hamilton Company (US)
  • MIMETAS (Netherlands)
  • Emulate (US)
  • Hµrel Corporation (US)
  • QGel SA (Switzerland)
  • SynVivo (US)
  • Advanced BioMatrix (US)
  • Greiner Bio-One International (Austria)
  • PromoCell (Germany)

Research Coverage:

The report provides an overview of the 3D cell culture market. It aims at estimating the market size and growth potential of this market across different segments such as product, application, end user, and region. The report also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help the market leaders/new entrants in the 3D cell culture market by providing them with the closest approximations of revenues for the overall market and its subsegments. This report will help stakeholders to understand the competitive landscape better and gain insights to position their businesses and help companies adopt suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provide them with information regarding key market drivers and opportunities.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
  • 2.2 RESEARCH METHODOLOGY STEPS
    • 2.2.1 SECONDARY DATA
      • 2.2.1.1 Key data from secondary sources
    • 2.2.2 PRIMARY DATA
      • 2.2.2.1 Key data from primary sources
    • 2.2.3 KEY INSIGHTS FROM PRIMARY SOURCES
  • 2.3 MARKET SIZE ESTIMATION METHODOLOGY
    • 2.3.1 REVENUE MAPPING-BASED MARKET ESTIMATION
  • 2.4 MARKET DATA ESTIMATION AND TRIANGULATION
  • 2.5 ASSUMPTIONS OF THE STUDY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 3D CELL CULTURE MARKET OVERVIEW
  • 4.2 SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2019-2024 (USD MILLION)
  • 4.3 3D CELL CULTURE MARKET SHARE, BY END USER & REGION (2018)
  • 4.4 3D CELL CULTURE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 MARKET DRIVERS
      • 5.2.1.1 Increasing focus on developing alternatives to animal testing
      • 5.2.1.2 Growing focus on personalized medicine
      • 5.2.1.3 Increasing incidence of chronic diseases
      • 5.2.1.4 Availability of funding for research
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Lack of infrastructure for 3D cell-based research
      • 5.2.2.2 High cost of cell biology research
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Emergence of microfluidics-based 3D cell culture
      • 5.2.3.2 Emerging economies
      • 5.2.3.3 Regenerative medicine-An alternative to organ transplantation
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Lack of consistency in 3D cell culture products

6 3D CELL CULTURE MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
  • 6.2 SCAFFOLD-BASED 3D CELL CULTURES
    • 6.2.1 HYDROGELS/ECM ANALOGS
      • 6.2.1.1 Hydrogels/ECM analogs dominate the scaffold-based 3D cell cultures market
    • 6.2.2 SOLID SCAFFOLDS
      • 6.2.2.1 Solid scaffolds are widely adopted in regenerative medicine and preclinical in vitro testing
    • 6.2.3 MICROPATTERNED SURFACES
      • 6.2.3.1 Micropatterned surfaces enhance the expression of enzymes levels and drug reactivity
  • 6.3 SCAFFOLD-FREE 3D CELL CULTURES
    • 6.3.1 LOW ATTACHMENT PLATES
      • 6.3.1.1 Low attachment plates are expected to grow at the highest rate in the scaffold-free 3D cell cultures market
    • 6.3.2 HANGING DROP PLATES
      • 6.3.2.1 Hanging drop plates are widely used in stem cell differentiation and cytotoxicity research
    • 6.3.3 3D BIOREACTORS
      • 6.3.3.1 3D bioreactors are commonly used in the mass production of cells
    • 6.3.4 3D PETRI DISHES
      • 6.3.4.1 Europe will witness the highest growth in the 3D Petri dishes market
  • 6.4 MICROFLUIDICS-BASED 3D CELL CULTURES
    • 6.4.1 MICROFLUIDICS-BASED 3D CELL CULTURES WILL GROW AT THE HIGHEST RATE IN THE 3D CELL CULTURE MARKET
  • 6.5 MAGNETIC & BIOPRINTED 3D CELL CULTURES
    • 6.5.1 3D CELL CULTURE CAN BE FORMED WITHOUT MEDIA IN MAGNETIC LEVITATION

7 3D CELL CULTURE MARKET, BY APPLICATION

  • 7.1 INTRODUCTION
  • 7.2 CANCER & STEM CELL RESEARCH
    • 7.2.1 RISING PREVALENCE OF CANCER IS A KEY FACTOR DRIVING THE GROWTH OF THIS SEGMENT
  • 7.3 DRUG DISCOVERY & TOXICOLOGY TESTING
    • 7.3.1 INCREASING ADOPTION OF PERSONALIZED MEDICINES TO SUPPORT MARKET GROWTH
  • 7.4 TISSUE ENGINEERING & REGENERATIVE MEDICINE
    • 7.4.1 EUROPE IS EXPECTED TO REGISTER THE HIGHEST GROWTH IN THE TISSUE ENGINEERING & REGENERATIVE MEDICINE MARKET

8 3D CELL CULTURE MARKET, BY END USER

  • 8.1 INTRODUCTION
  • 8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • 8.2.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ARE THE LARGEST END USERS OF 3D CELL CULTURE
  • 8.3 RESEARCH INSTITUTES
    • 8.3.1 INCREASING GOVERNMENT FUNDING FOR RESEARCH & HIGH PREVALENCE OF CANCER ARE DRIVING MARKET GROWTH
  • 8.4 COSMETICS INDUSTRY
    • 8.4.1 FOCUS ON DEVELOPING ALTERNATIVES TO ANIMAL TESTING IS A KEY FACTOR DRIVING MARKET GROWTH
  • 8.5 OTHER END USERS

9 3D CELL CULTURE MARKET, BY REGION

  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    • 9.2.1 US
      • 9.2.1.1 The US dominates the North American market
    • 9.2.2 CANADA
      • 9.2.2.1 Advancements in the field of regenerative medicine to drive market growth in Canada
  • 9.3 EUROPE
    • 9.3.1 GERMANY
      • 9.3.1.1 Increasing investments by various key players and growing funding from government organizations to drive the market
    • 9.3.2 UK
      • 9.3.2.1 Growth in the life sciences industry to drive market growth in the UK
    • 9.3.3 FRANCE
      • 9.3.3.1 Growth in the biotechnology industry to drive market growth in France
    • 9.3.4 ROE
  • 9.4 ASIA PACIFIC
    • 9.4.1 JAPAN
      • 9.4.1.1 Japan to dominate the Asia Pacific market
    • 9.4.2 CHINA
      • 9.4.2.1 Government support & strategic initiatives by key players to strengthen the biotechnology sector in China
    • 9.4.3 INDIA
      • 9.4.3.1 Growth in the life sciences industry to support market growth in India
    • 9.4.4 ROAPAC
  • 9.5 REST OF THE WORLD

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 MARKET SHARES ANALYSIS, 2018
  • 10.3 COMPETITIVE LEADERSHIP MAPPING
    • 10.3.1 VISIONARY LEADERS
    • 10.3.2 DYNAMIC DIFFERENTIATORS
    • 10.3.3 INNOVATORS
    • 10.3.4 EMERGING COMPANIES
  • 10.4 COMPETITIVE SITUATION AND TRENDS
    • 10.4.1 PRODUCT LAUNCHES & UPGRADES
    • 10.4.2 EXPANSIONS
    • 10.4.3 ACQUISITIONS
    • 10.4.4 PARTNERSHIPS, AGREEMENTS, ALLIANCES, AND COLLABORATIONS
    • 10.4.5 OTHER STRATEGIES

11 COMPANY PROFILES

(Business overview, Products offered, Recent developments & MnM View)*

  • 11.1 THERMO FISHER SCIENTIFIC
  • 11.2 CORNING INCORPORATED
  • 11.3 MERCK KGAA
  • 11.4 LONZA GROUP
  • 11.5 REPROCELL
  • 11.6 3D BIOTEK LLC
  • 11.7 EMULATE, INC.
  • 11.8 CN BIO INNOVATIONS LIMITED
  • 11.9 HAMILTON COMPANY
  • 11.10 INSPHERO AG
  • 11.11 KIRKSTALL, LTD.
  • 11.12 MIMETAS BV
  • 11.13 TISSUSE GMBH
  • 11.14 SYNTHECON INCORPORATED
  • 11.15 QGEL SA

Details on Business overview, Products offered, Recent developments & MnM View might not be captured in case of unlisted companies.

  • 11.16 OTHER KEY PLAYERS
    • 11.16.1 GREINER BIO-ONE INTERNATIONAL GMBH
    • 11.16.2 PROMOCELL GMBH
    • 11.16.3 ADVANCED BIOMATRIX, INC.
    • 11.16.4 HµREL CORPORATION
    • 11.16.5 SYNVIVO, INC.

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 AVAILABLE CUSTOMIZATIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS

LIST OF TABLES

  • TABLE 1: GROWTH IN THE NUMBER OF PERSONALIZED MEDICINES
  • TABLE 2: PREVALENCE OF DIABETES, BY REGION, 2000 VS. 2030
  • TABLE 3: INCIDENCE OF CANCER, BY TYPE, 2018 VS. 2040
  • TABLE 4: 3D CELL CULTURE MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 5: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 6: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 7: NORTH AMERICA: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 8: EUROPE: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 9: ASIA PACIFIC: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 10: HYDROGELS/ECM ANALOGS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 11: NORTH AMERICA: HYDROGELS/ECM ANALOGS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 12: EUROPE: HYDROGELS/ECM ANALOGS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 13: ASIA PACIFIC: HYDROGELS/ECM ANALOGS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 14: SOLID SCAFFOLDS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 15: NORTH AMERICA: SOLID SCAFFOLDS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 16: EUROPE: SOLID SCAFFOLDS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 17: ASIA PACIFIC: SOLID SCAFFOLDS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 18: MICROPATTERNED SURFACES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 19: NORTH AMERICA: MICROPATTERNED SURFACES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 20: EUROPE: MICROPATTERNED SURFACES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 21: ASIA PACIFIC: MICROPATTERNED SURFACES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 22: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 23: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 24: NORTH AMERICA: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 25: EUROPE: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 26: ASIA PACIFIC: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 27: LOW ATTACHMENT PLATES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 28: NORTH AMERICA: LOW ATTACHMENT PLATES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 29: EUROPE: LOW ATTACHMENT PLATES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 30: ASIA PACIFIC: LOW ATTACHMENT PLATES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 31: HANGING DROP PLATES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 32: NORTH AMERICA: HANGING DROP PLATES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 33: EUROPE: HANGING DROP PLATES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 34: ASIA PACIFIC: HANGING DROP PLATES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 35: 3D BIOREACTORS MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 36: NORTH AMERICA: 3D BIOREACTORS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 37: EUROPE: 3D BIOREACTORS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 38: ASIA PACIFIC: 3D BIOREACTORS MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 39: 3D PETRI DISHES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 40: NORTH AMERICA: 3D PETRI DISHES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 41: EUROPE: 3D PETRI DISHES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 42: ASIA PACIFIC: 3D PETRI DISHES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 43: MICROFLUIDICS-BASED 3D CELL CULTURE MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 44: NORTH AMERICA: MICROFLUIDICS-BASED 3D CELL CULTURE MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 45: EUROPE: MICROFLUIDICS-BASED 3D CELL CULTURE MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 46: ASIA PACIFIC: MICROFLUIDICS-BASED 3D CELL CULTURE MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 47: MAGNETIC & BIOPRINTED 3D CELL CULTURES MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 48: NORTH AMERICA: MAGNETIC & BIOPRINTED 3D CELL CULTURES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 49: EUROPE: MAGNETIC & BIOPRINTED 3D CELL CULTURES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 50: ASIA PACIFIC: MAGNETIC & BIOPRINTED 3D CELL CULTURES MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 51: 3D CELL CULTURE MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 52: 3D CELL CULTURE MARKET FOR CANCER & STEM CELL RESEARCH, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 53: NORTH AMERICA: 3D CELL CULTURE MARKET FOR CANCER & STEM CELL RESEARCH, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 54: EUROPE: 3D CELL CULTURE MARKET FOR CANCER & STEM CELL RESEARCH, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 55: ASIA PACIFIC: 3D CELL CULTURE MARKET FOR CANCER & STEM CELL RESEARCH, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 56: 3D CELL CULTURE MARKET FOR DRUG DISCOVERY & TOXICOLOGY TESTING, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 57: NORTH AMERICA: 3D CELL CULTURE MARKET FOR DRUG DISCOVERY & TOXICOLOGY TESTING, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 58: EUROPE: 3D CELL CULTURE MARKET FOR DRUG DISCOVERY & TOXICOLOGY TESTING, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 59: ASIA PACIFIC: 3D CELL CULTURE MARKET FOR DRUG DISCOVERY & TOXICOLOGY TESTING, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 60: 3D CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 61: NORTH AMERICA: 3D CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 62: EUROPE: 3D CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 63: ASIA PACIFIC: 3D CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 64: 3D CELL CULTURE MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 65: 3D CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 66: NORTH AMERICA: 3D CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 67: EUROPE: 3D CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 68: ASIA PACIFIC: 3D CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 69: 3D CELL CULTURE MARKET FOR RESEARCH INSTITUTES, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 70: NORTH AMERICA: 3D CELL CULTURE MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 71: EUROPE: 3D CELL CULTURE MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 72: ASIA PACIFIC: 3D CELL CULTURE MARKET FOR RESEARCH INSTITUTES, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 73: 3D CELL CULTURE MARKET FOR THE COSMETICS INDUSTRY, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 74: NORTH AMERICA: 3D CELL CULTURE MARKET FOR THE COSMETICS INDUSTRY, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 75: EUROPE: 3D CELL CULTURE MARKET FOR THE COSMETICS INDUSTRY, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 76: ASIA PACIFIC: 3D CELL CULTURE MARKET FOR THE COSMETICS INDUSTRY, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 77: 3D CELL CULTURE MARKET FOR OTHER END USERS, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 78: NORTH AMERICA: 3D CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 79: EUROPE: 3D CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 80: ASIA PACIFIC: 3D CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 81: 3D CELL CULTURE MARKET, BY REGION, 2017-2024 (USD MILLION)
  • TABLE 82: NORTH AMERICA: 3D CELL CULTURE MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 83: NORTH AMERICA: 3D CELL CULTURE MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 84: NORTH AMERICA: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 85: NORTH AMERICA: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 86: NORTH AMERICA: 3D CELL CULTURE MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 87: NORTH AMERICA: 3D CELL CULTURE MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 88: US: 3D CELL CULTURE MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 89: US: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 90: US: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 91: US: 3D CELL CULTURE MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 92: US: 3D CELL CULTURE MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 93: CANADA: 3D CELL CULTURE MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 94: CANADA: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 95: CANADA: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 96: CANADA: 3D CELL CULTURE MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 97: CANADA: 3D CELL CULTURE MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 98: EUROPE: 3D CELL CULTURE MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 99: EUROPE: 3D CELL CULTURE MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 100: EUROPE: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 101: EUROPE: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 102: EUROPE: 3D CELL CULTURE MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 103: EUROPE: 3D CELL CULTURE MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 104: GERMANY: 3D CELL CULTURE MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 105: GERMANY: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 106: GERMANY: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 107: GERMANY: 3D CELL CULTURE MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 108: GERMANY: 3D CELL CULTURE MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 109: UK: 3D CELL CULTURE MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 110: UK: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 111: UK: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 112: UK: 3D CELL CULTURE MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 113: UK: 3D CELL CULTURE MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 114: FRANCE: 3D CELL CULTURE MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 115: FRANCE: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 116: FRANCE: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 117: FRANCE: 3D CELL CULTURE MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 118: FRANCE: 3D CELL CULTURE MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 119: ROE: 3D CELL CULTURE MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 120: ROE: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 121: ROE: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 122: ROE: 3D CELL CULTURE MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 123: ROE: 3D CELL CULTURE MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 124: APAC: 3D CELL CULTURE MARKET, BY COUNTRY, 2017-2024 (USD MILLION)
  • TABLE 125: APAC: 3D CELL CULTURE MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 126: APAC: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 127: APAC: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 128: APAC: 3D CELL CULTURE MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 129: APAC: 3D CELL CULTURE MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 130: JAPAN: 3D CELL CULTURE MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 131: JAPAN: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 132: JAPAN: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 133: JAPAN: 3D CELL CULTURE MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 134: JAPAN: 3D CELL CULTURE MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 135: CHINA: 3D CELL CULTURE MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 136: CHINA: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 137: CHINA: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 138: CHINA: 3D CELL CULTURE MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 139: CHINA: 3D CELL CULTURE MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 140: INDIA: 3D CELL CULTURE MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 141: INDIA: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 142: INDIA: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 143: INDIA: 3D CELL CULTURE MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 144: INDIA: 3D CELL CULTURE MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 145: ROAPAC: 3D CELL CULTURE MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 146: ROAPAC: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 147: ROAPAC: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 148: ROAPAC: 3D CELL CULTURE MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 149: ROAPAC: 3D CELL CULTURE MARKET, BY END USER, 2017-2024 (USD MILLION).
  • TABLE 150: ROW: 3D CELL CULTURE MARKET, BY PRODUCT, 2017-2024 (USD MILLION)
  • TABLE 151: ROW: SCAFFOLD-BASED 3D CELL CULTURES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 152: ROW: SCAFFOLD-FREE 3D CELL CULTURES MARKET, BY TYPE, 2017-2024 (USD MILLION)
  • TABLE 153: ROW: 3D CELL CULTURE MARKET, BY APPLICATION, 2017-2024 (USD MILLION)
  • TABLE 154: ROW: 3D CELL CULTURE MARKET, BY END USER, 2017-2024 (USD MILLION)
  • TABLE 155: EXCHANGE RATES (UTILIZED FOR CONVERSION OF EUR TO USD)
  • TABLE 156: EXCHANGE RATES (UTILIZED FOR CONVERSION OF CHF TO USD)

LIST OF FIGURES

  • FIGURE 1: RESEARCH METHODOLOGY STEPS: 3D CELL CULTURE MARKET
  • FIGURE 2: RESEARCH DESIGN
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4: RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • FIGURE 5: MARKET SIZE ESTIMATION: OVERALL 3D CELL CULTURE MARKET
  • FIGURE 6: DATA TRIANGULATION METHODOLOGY
  • FIGURE 7: 3D CELL CULTURE MARKET, BY PRODUCT, 2019 VS. 2024 (USD MILLION)
  • FIGURE 8: 3D CELL CULTURE MARKET, BY APPLICATION, 2019 VS. 2014 (USD MILLION)
  • FIGURE 9: 3D CELL CULTURE MARKET, BY END USER, 2019-2024 (USD MILLION)
  • FIGURE 10: GEOGRAPHICAL SNAPSHOT OF THE 3D CELL CULTURE MARKET
  • FIGURE 11: INCREASING FOCUS ON DEVELOPING ALTERNATIVES TO ANIMAL TESTING IS A MAJOR FACTOR DRIVING THE ADOPTION OF 3D CELL CULTURE SOLUTIONS
  • FIGURE 12: HYDROGELS/ECM ANALOGS ARE EXPECTED TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
  • FIGURE 13: PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET IN 2018
  • FIGURE 14: EUROPE IS EXPECTED TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD
  • FIGURE 15: 3D CELL CULTURE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 16: NORTH AMERICA: 3D CELL CULTURE MARKET SNAPSHOT
  • FIGURE 17: EUROPE: 3D CELL CULTURE MARKET SNAPSHOT
  • FIGURE 18: KEY PLAYERS ADOPTED ORGANIC AS WELL AS INORGANIC GROWTH STRATEGIES
  • FIGURE 19: MARKET EVOLUTION FRAMEWORK
  • FIGURE 20: 3D CELL CULTURE MARKET SHARES ANALYSIS, BY KEY PLAYER, 2018
  • FIGURE 21: COMPETITIVE LEADERSHIP MAPPING
  • FIGURE 22: THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
  • FIGURE 23: CORNING INCORPORATED: COMPANY SNAPSHOT
  • FIGURE 24: MERCK KGAA: COMPANY SNAPSHOT
  • FIGURE 25: LONZA GROUP: COMPANY SNAPSHOT
Back to Top